Kotra Industries Berhad Full Year 2024 Earnings: Misses Expectations

Simply Wall St

November 04, 2024

Kotra Industries Berhad (KLSE:KOTRA) Full Year 2024 Results

Key Financial Results

Revenue: RM226.6m (down 6.5% from FY 2023).
Net income: RM44.6m (down 32% from FY 2023).
Profit margin: 20% (down from 27% in FY 2023). The decrease in margin was primarily driven by lower revenue.
EPS: RM0.30 (down from RM0.44 in FY 2023).

revenue-and-expenses-breakdown — KLSE:KOTRA Revenue and Expenses Breakdown November 4th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Kotra Industries Berhad Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 7.4%. Earnings per share (EPS) also missed analyst estimates by 11%.

The primary driver behind last 12 months revenue was the Malaysia segment contributing a total revenue of RM151.8m (67% of total revenue). The largest operating expense was General & Administrative costs, amounting to RM53.1m (44% of total expenses). Explore how KOTRA's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 9.9% growth forecast for the Pharmaceuticals industry in Asia.

Performance of the market in Malaysia.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Kotra Industries Berhad, and understanding it should be part of your investment process.

Valuation is complex, but we're here to simplify it.

Discover if Kotra Industries Berhad might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.